Clinical Trials Directory

Trials / Unknown

UnknownNCT05424614

Study on the Prognostic Prediction Model of Patients With Acute Intracerebral Hemorrhage by Artificial Intelligence

Capital's Funds for Health Improvement and Research

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Beijing Neurosurgical Institute · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Spontaneous intracerebral hemorrhage(SICH) is the most lethal and disabling stroke. Timely and accurate assessment of patient prognosis could facilitate clinical decision making and stratified management of patients and is important for improving patient clinical prognosis. However, current studies on the prediction of prognosis of patients with SICH are limited and only include a single variable, with less precise results and inconvenient clinical application, which may lead to delays in effective patient treatment. Our group's previous studies on SICH showed that hematoma heterogeneity and the degree of contrast extravasation within the hematoma are closely related to the clinical outcome of patients, but they are difficult to describe quantitatively based on imaging signs. Based on this, we propose to use radiomics to quantitatively extract hematoma features from NCCT and CTA images, combine them with patients' clinical information and laboratory tests, study their relationship with the prognosis of cerebral hemorrhage, and use artificial intelligence to establish a rapid and accurate prognostic prediction model for patients with SICH, which is of great significance to guide clinical individualized treatment.

Conditions

Interventions

TypeNameDescription
OTHERFunctional outcome follow-up of patientsPatients were followed up by telephone after discharge, every 4 weeks, until the end of the 3-month follow-up. Their functional status was determined based on the MRS score (modified Rankin Scale). Those with less than 3 points were defined as having a good prognosis, and those with more than 3 points were defined as having a poor prognosis

Timeline

Start date
2022-05-13
Primary completion
2024-09-30
Completion
2024-12-30
First posted
2022-06-21
Last updated
2022-06-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05424614. Inclusion in this directory is not an endorsement.